The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. - Wikidata - wikimedia - TriplyDB

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

http://www.wikidata.org/entity/Q30490283

about

Mind and body therapy for fibromyalgia Acupuncture for treating fibromyalgia.Exploring Genetic Susceptibility to Fibromyalgia Fibromyalgia: evolving concepts over the past 2 decades.A framework for fibromyalgia management for primary care providers Fibromyalgia and disability adjudication: no simple solutions to a complex problem Validation of a Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR).Exergames for women with fibromyalgia: a randomised controlled trial to evaluate the effects on mobility skills, balance and fear of falling.The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.A report of the autonomic symptom profile in patients with fibromyalgia A pilot study of myofascial release therapy compared to Swedish massage in fibromyalgia.'Isn't it ironic?' Beliefs about the unacceptability of emotions and emotional suppression relate to worse outcomes in fibromyalgia.A diagnostic biomarker profile for fibromyalgia syndrome based on an NMR metabolomics study of selected patients and controls Multidimensional daily diary of fatigue-fibromyalgia-17 items (MDF-fibro-17): part 2 psychometric evaluation in fibromyalgia patients "Fibromyalgia and quality of life: mapping the revised fibromyalgia impact questionnaire to the preference-based instruments".Effects of Vitamin D Therapy on Quality of Life in Patients with Fibromyalgia Psychological Resilience, Affective Mechanisms and Symptom Burden in a Tertiary-care Sample of Patients with Fibromyalgia.Virtual reality exposure therapy as treatment for pain catastrophizing in fibromyalgia patients: proof-of-concept study (Study Protocol)A Comparison of Fibromyalgia Symptoms in Patients with Healthy versus Depressive, Low and Reactive Affect Balance Styles.Pain severity and neuropathic pain symptoms in primary Sjögren's syndrome: a comparison study of seropositive and seronegative Sjögren's syndrome patients.Cross-cultural adaptation and validation of a Bengali version of the modified fibromyalgia impact questionnaire.Milnacipran for the management of fibromyalgia syndrome.OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis Using a partially randomized patient preference study design to evaluate the therapeutic effect of acupuncture and cupping therapy for fibromyalgia: study protocol for a partially randomized controlled trial.Efficacy of long-term milnacipran treatment in patients meeting different thresholds of clinically relevant pain relief: subgroup analysis of a randomized, double-blind, placebo-controlled withdrawal study.Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria.Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population.Effect of transcutaneous electrical nerve stimulation on pain, function, and quality of life in fibromyalgia: a double-blind randomized clinical trial.Preliminary evidence of a blunted anti-inflammatory response to exhaustive exercise in fibromyalgia.Pharmacotherapy for fibromyalgia.IMPACT--Integrative Medicine PrimAry Care Trial: protocol for a comparative effectiveness study of the clinical and cost outcomes of an integrative primary care clinic model Parasympathetic reactivity in fibromyalgia and temporomandibular disorder: associations with sleep problems, symptom severity, and functional impairment.A comprehensive evaluation of standardized assessment tools in the diagnosis of fibromyalgia and in the assessment of fibromyalgia severity.Mast Cell Stabilizer (Ketotifen) in Fibromyalgia: Phase 1 Randomized Controlled Clinical Trial.Postural control deficits in people with fibromyalgia: a pilot study.Development of responder definitions for fibromyalgia clinical trials Development and initial validation of a brief self-report measure of cognitive dysfunction in fibromyalgia.Traditional Chinese medicine diagnoses in a sample of women with fibromyalgia Cost-utility and biological underpinnings of Mindfulness-Based Stress Reduction (MBSR) versus a psychoeducational programme (FibroQoL) for fibromyalgia: a 12-month randomised controlled trial (EUDAIMON study).Fibromyalgia Impact and Mindfulness Characteristics in 4986 People with Fibromyalgia

P2860

Q24186559-B0E0F572-7858-467B-9CE0-1765A3184F14 Q24202806-70072B41-0C19-44FC-A311-0808884EB401 Q26797418-2017C8A9-E77F-4C91-958D-16D2F9A7A029 Q26999442-E56F8AD5-4656-4F8A-9797-A83806DB2221 Q27022200-8275FAE6-2B8B-455E-8310-BD29811150E3 Q28649435-DF5FEFE6-AC18-4D90-974D-66FE9BEA42C4 Q30544617-94E609EF-690D-44FC-AB97-B8002E988F14 Q30572581-0E1BDCEF-BB32-4F21-A25B-83085ED311B0 Q31096632-CA03BBB5-BE77-40D4-8B3E-C1EE8C987091 Q33163878-274D9C24-C0E1-4BAC-A44B-DF9464A0C465 Q33355999-5D4E290A-D34D-4583-BE41-67D5108A85B8 Q33592020-A10761F0-B208-4431-9D72-13ABDCDA23D2 Q33660504-8D637EB9-E198-4792-80D5-CF086A4FC315 Q33706811-947F7B72-70D0-49D6-8C50-150B10D2C184 Q33743545-3B4C0B58-9EB4-47DE-BBE5-D153BA4EB167 Q33794327-2E85C8D0-2940-4670-9F25-3FCCE9A9234F Q33831726-5C3D8B47-E9FD-4FC4-9CC9-5F847DCEE823 Q33884944-9CBA29CD-9FE9-4A3B-AB94-EA06444D9B73 Q33935597-D7D131B4-84E9-4A32-9C51-72BA14D6DF9D Q34065440-DADAFCAC-5799-4045-85E5-6F60DCD76FAA Q34394421-926F3AE3-A943-43CD-BE61-4E297DF4F107 Q34418392-945FA16F-4C20-4581-AA24-E5C798987073 Q34459831-CA781FF3-548E-4454-A591-8FDB91F203CD Q34485247-9D6CF8BB-97F3-43C6-B1FB-5E288CFE08B7 Q34584386-D6756AA8-35EB-4FE8-88E3-BD56C3220B3E Q34659490-0AFBB009-E21F-4CCA-94A8-591701B6F183 Q34661873-4AC0C6E9-01B2-492F-B98B-2CEAFA3995BC Q34965703-1D9ADBD2-2DB2-46C4-AFE2-668DE894D0EC Q35039967-62433267-C50F-4CC2-B2B3-6CBE823CDE15 Q35092347-B084144B-797E-4E3E-A5F4-452ACDBCD202 Q35141267-7C9D3E8B-5159-4F57-A36D-AB4223961AC4 Q35155890-6A4EA3A0-CCC3-4065-8314-92F4A280FC89 Q35431377-6DE67C1C-617D-4AAF-98C2-FC9816AD2CC8 Q35563612-1B1BD0EE-8043-45F4-BE30-36FA456C142E Q35617687-1A4C8342-1AB4-415B-A88C-5D8147D20D03 Q35656228-A5C5C55C-6D10-42BD-8EBA-705A8BAECCBA Q35685090-98AA9CB0-D1EB-49B6-9D23-9DB3A96C80C0 Q35848916-68E8B5AC-B5E1-4A0A-A1AB-87F3BCF76603 Q35938110-12EF845D-B675-4363-8030-CEEF058356BD Q36003371-DD80D8B3-E995-4F0F-8054-C256ADE3D8CE

P2860

The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

http://www.wikidata.org/entity/Q30490283

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@ast

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@en

type

label

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@ast

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@en

prefLabel

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@ast

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@en

P1433

Q30490283-DDCA6076-960D-4E25-BF1E-601F15F01590

P1476

Q30490283-EE2EEE67-AD9F-4444-930D-C8FBD151FF36

P2093

Q30490283-31EEA362-93D7-4754-820F-B1C81BFBE139

Q30490283-9DF63AE5-614C-4919-BD64-8916D3D05898

Q30490283-BD14329E-8791-4989-AAC5-20822B5925D3

Q30490283-BF891D03-96C3-445D-A600-2A6DC951FFF8

Q30490283-C17E8E36-C8C1-4259-9771-7A6650992201

P2860

Q30490283-101E5FB9-F4A0-4E01-9879-A5D248D4077B

Q30490283-140951BC-E647-4182-87B1-E395C9A89DED

Q30490283-275E4342-D5A5-47DA-9B96-E802A88ED21D

Q30490283-2E8E1187-0DAA-4C9F-90FB-E011B20DC16B

Q30490283-2E95E303-52B2-4A11-8A57-CCEDB713C187

Q30490283-5066D5B2-4691-4242-A4A7-F11B5D5671C3

Q30490283-63A61E68-B696-4BCD-87FB-42EEA7FF636F

Q30490283-686C1B12-467F-4CDA-89ED-A0431DD509C4

Q30490283-6BFC80B7-FEDC-4EA7-9D13-7EA31B699D2D

Q30490283-75D64FB6-F619-4EC6-BA3A-EF347134EBA6

P2888

Q30490283-8AE8C196-EC6F-40CB-A1C8-F31BF17518F0

P304

Q30490283-5E07742B-0D01-442C-9CE1-0DE0B5619867

P31

Q30490283-91CC8423-CF84-4ABD-9BC4-3092800F5EA9

P356

Q30490283-AC698291-5D01-4A8A-B970-2CC0C0D5BE70

P433

Q30490283-8DADABA3-A7F9-462E-9EC4-7A1436A1C0AC

P478

Q30490283-3A015DD5-9BB4-47B9-BF3F-9162F11D91F6

P50

Q30490283-AFC6A630-46D1-403E-853D-7ED3C225EF78

P577

Q30490283-3ACBAC88-F50E-4F69-BB10-6B31FC0E38C7

P5875

Q30490283-C6BC4818-7EB4-4A4D-933D-20A0DDDD8F2F

P6179

Q30490283-8FE03343-2A83-48DA-8776-86DDD335396A

P698

Q30490283-66022F9B-92A6-469E-B784-821889B68570

P921

Q30490283-2B217A7C-6D91-4113-A773-B8CF1B9F959B

Q30490283-902D2C68-76E4-42A9-AD85-1DFE68E48EB7

P932

Q30490283-B6194574-9001-4994-8BF1-3D18129C2690

P356

P1433

Arthritis Research and Therapy

P1476

The Revised Fibromyalgia Impac ...... n and psychometric properties.

@en

P2093

Bobby K Han

http://www.w3.org/2001/XMLSchema#string

Kim D Jones

http://www.w3.org/2001/XMLSchema#string

Rachel Ward

http://www.w3.org/2001/XMLSchema#string

Rebecca L Ross

http://www.w3.org/2001/XMLSchema#string

Ronald Friend

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

An internet survey of 2,596 people with fibromyalgia

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

Responsiveness of fibromyalgia clinical trial outcome measures.

A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?

Visual analog scales in formats other than a 10 centimeter horizontal line to assess pain and other clinical data.

Fibromyalgia is associated with impaired balance and falls.

The fibromyalgia impact questionnaire: development and validation.

Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen.

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.

P2888

P304

R120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2783

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280321029

http://www.w3.org/2001/XMLSchema#string

P6179

1043914244

http://www.w3.org/2001/XMLSchema#string

P698

19664287

http://www.w3.org/2001/XMLSchema#string

P921

P932

2745803

http://www.w3.org/2001/XMLSchema#string